OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Unknown
(1)
Proteomics
(1)
Organisms
Helicobacter pylori G27
(1)
Repository
iProX
(1)
Publication Date
2024
(1)
Release Date
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.
Not available
S-EPMC4279237
|
biostudies-literature
Cite
Targets Identification of NPB by the combined use of DARTS technology and proteomics
We found that the stability of OorD protein increased with the combination of DARTS technology and mass spectrometry identification.This result suggests that OorD may be a target of NPB.
ORGANISM(S):
Helicobacter Pylori G27
2024-11-26
|
PXD058270
|
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets